Duraflu Tablet
Product Images NDC 50991-535

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Duraflu (NDC 50991-535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Poly Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 50991-535-01duraflu™expectorant/ Nasal Decongestantantitussive/pain Reliever100 Tablets (Duraflu Tablets 01)

Drug Facts panels for Duraflu tablets, containing Acetaminophen 325 mg, Dextromethorphan HBr 20 mg, Guaifenesin 200 mg, and Pseudoephedrine HCl 60 mg. The panels list active ingredients, their purposes, temporary relief uses, warnings including liver damage and allergy information, instructions for use, and warnings to consult a doctor under certain conditions. Additional advice covers stopping product use when symptoms worsen or persist.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.